Investor insights
Sectors invested in
Biotechnology2
Health Care1
Therapeutics1
Manufacturing1
Medical Device1
MedTech1
Tissue Reconstruction1
Synthetic Polymers1
Innovation1
Funding rounds participated in
$60M sweet spot round size
Most of their 2 investments are in rounds between $54M and $66M
Investor type
Venture Capital
Basic info
Industry
venture capital and private equity principals
Sectors
data-driven medicine
venture capital
Financial Services
cross-border
private equity
investment
life sciences
technology
healthcare
Date founded
2021
Investments made
T
TISSIUM raised $54M on May 23, 2023
Investors: FSI - Fonds Stratégique d'Investissement, Sofinnova Partners, Crédit Mutuel Innovation and Cathay Health
A
Ascend Gene & Cell Therapies raised $66M on May 9, 2023
Investors: Digitalis Ventures, Abingworth, Ajinomoto Sales (Thailand) Co., Ltd, -, DCVC Bio and Cathay Health